BioMarin may build second plant in Ireland

US biopharma giant has extended its Cork facility amid rising global demand for pioneering treatments

US biopharmaceuticals giant BioMarin is considering building a second manufacturing plant in Ireland pending approval of new drugs.

The news emerged yesterday as the company marked the opening of a major extension of its Shanbally plant in Cork, its only manufacturing facility outside the US.